Second Generation DICART Prototype Validation

Second Generation DICART Prototype Validation for Patients With Acute Circulatory Failure

Capillary refill time (CRT) is a clinical sign for diagnosis of acute circulatory failure and response to treatment but is also associated with prognosis in patient with shock.

CRT is clinically evaluated by physician with a high risk of inter and intra evaluator variations, depending, for example, on measurement site, pressure applicated or visual evaluation.

The investigator hypothesizes that CRT measurement with second generation DICART prototype will be well correlated with clinical measurement.

Inclusion Criteria:

->18 years old

• Acute circulatory failure
• Written informed consent given by patient or its relatives

Exclusion Criteria:

• Pregnant women, breastfeeding women, childbearing age women without oral contraception
• Cutaneous lesion at measurement site
• Patient under legal protection
• Patient already included in another interventional clinical trial